% This is the RIPE Database query service.
% The objects are in RPSL format.
%
% The RIPE Database is subject to Terms and Conditions.
% See http://www.ripe.net/db/support/db-terms-conditions.pdf
% Information related to '194.34.64.0 - 194.34.95.255'
% Abuse contact for '194.34.64.0 - 194.34.95.255' is '[email protected]'
inetnum: 194.34.64.0 - 194.34.95.255
netname: ZENECA-CTL
country: GB
country: US
language: EN
country: JP
language: JA
country: AU
language: EN
org: ORG-AP53-RIPE
admin-c: JD9774-RIPE
tech-c: JD9774-RIPE
mnt-by: RIPE-NCC-END-MNT
mnt-by: JD817-MNT
status: ASSIGNED PI
created: 1970-01-01T00:00:00Z
last-modified: 2019-12-17T17:31:16Z
source: RIPE
sponsoring-org: ORG-AUL4-RIPE
organisation: ORG-AP53-RIPE
org-name: AstraZeneca PLC
country: ES
org-type: OTHER
address: AstraZeneca UK Limited 2 Kingdom Street London W2 6BD United Kingdom
e-mail: [email protected]
abuse-c: AC29544-RIPE
mnt-ref: DW310-MNT
mnt-by: DW310-MNT
mnt-by: JD817-MNT
created: 2012-07-24T15:25:07Z
last-modified: 2022-12-01T16:15:50Z
source: RIPE
person: Joel Driver
address: Macclesfield, UK
phone: +447469408120
nic-hdl: JD9774-RIPE
mnt-by: JD817-MNT
created: 2017-08-14T18:57:05Z
last-modified: 2017-08-14T18:57:05Z
source: RIPE
% This query was served by the RIPE Database Query Service version 1.105 (SHETLAND)